Cozen O’Connor: NDRI Elects David M. Albert to the Board of Directors

NDRI Elects David M. Albert to the Board of Directors

Monday, November 12, 2018

David Albert, director of Cozen O'Connor's Strategy, Emerging Business & Venture Capital Group, has been elected to the Board of Directors for the National Disease Research Interchange. He was elected to a three-year term and will bring his experience and insight to the nation’s leading source of human organs, cells, and tissues for research.

To read the full press release, click here.

Contacts

David M. Albert

Member

dalbert@cozen.com

(215) 665-7277

People

Related Practice Areas